CYTOSORBENTS CORP

CTSONASDAQ

🏆 #3849 by market capEarnings Nov 3 · PostUS Equity

$467.83▲ $11.84 (+2.53%)

Simulated price

1h—

24h▲ 2.5%

7d—

14d—

30d—

1y—

🏦Market Cap

$23M

Small Cap

📈Revenue Growth (YoY)

+7.7%

Slowing

📊Gross Margin

71.0%

High

💵FCF Margin

—

⚖️P/S Ratio

0.6x

Cheap

Otter Score

59

Weak

Earnings

Q2 · 2026After-MarketReported 2026-08-06

Earnings Per Share

Actual

-0.07

Expected

-0.05

miss

−52.50%

Revenue

Actual

$9.63M

Expected

$9.53M

beat

+1.00%

Consensus estimates